Chargement en cours...
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
BACKGROUND: Fibulin-3 is a new potential biomarker for malignant mesothelioma (MM). This study evaluated the potential applicability of fibulin-3 plasma levels as a biomarker of response to treatment and its prognostic value for progressive disease within 18 months. The potential applicability of fi...
Enregistré dans:
| Publié dans: | Radiol Oncol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Versita, Warsaw
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4577225/ https://ncbi.nlm.nih.gov/pubmed/26401134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/raon-2015-0019 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|